Showing results (1031-1040 of 1,194) with videos related to
Sort By:
Pageof 120
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2008
Highly parallel identification of essential genes in cancer cellsBiao Luo, Hiu Wing Cheung, Aravind Subramanian, et al.Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.Pain Reports|July 14, 2026
Impact of chronic pain on the families of U.S. adultsJennifer S De La Rosa, Katherine E Herder, Rita D Romero, et al.Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationH B Salvesen, S L Carter, M Mannelqvist, et al.Cancer Research|August 15, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinomaDerek Y Chiang, Augusto Villanueva, Yujin Hoshida, et al.Biological Reviews of the Cambridge Philosophical Society|June 27, 2020
Scientists' warning on invasive alien speciesPetr Pyšek, Philip E Hulme, Dan Simberloff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.Gastroenterology|October 22, 2008
Pivotal role of mTOR signaling in hepatocellular carcinomaAugusto Villanueva, Derek Y Chiang, Pippa Newell, et al.Cancer Discovery|October 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung CancerFranziska Siegel, Stephan Siegel, Kristýna Kotýnková, et al.Pageof 120